Baccarini Manuela
Max F. Perutz Laboratories, Department of Microbiology and Immunobiology, The University of Vienna, Vienna Biocenter, Dr. Bohr Gasse 9, 1030 Vienna, Austria.
FEBS Lett. 2005 Jun 13;579(15):3271-7. doi: 10.1016/j.febslet.2005.03.024. Epub 2005 Mar 23.
More than 20 years ago, Raf was discovered as a cellular oncogene transduced by transforming retroviruses. Since then, the three Raf isoforms have been intensively studied, mainly as the kinases linking Ras to the MEK/ERK signaling module. As this pathway is activated in human cancer, the Raf kinases are considered promising therapeutic targets, and we have learned a lot about their regulation, targets, and functions. Do they still hold surprises? Recent gene targeting studies indicate that they do. This review focuses on the regulation and biology of the best-studied Raf isoform, Raf-1, in the context of its kinase-independent functions.
20多年前,Raf作为一种由转化逆转录病毒转导的细胞癌基因被发现。从那时起,人们对三种Raf亚型进行了深入研究,主要是将其作为连接Ras与MEK/ERK信号模块的激酶。由于该信号通路在人类癌症中被激活,Raf激酶被认为是很有前景的治疗靶点,并且我们已经对它们的调节、靶点和功能有了很多了解。它们是否仍有惊喜之处呢?最近的基因靶向研究表明确实如此。本综述聚焦于研究最为深入的Raf亚型Raf-1在其非激酶依赖性功能背景下的调节和生物学特性。